Pub. Date : 2002 Apr
PMID : 11893554
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Pretreatment with the ADH inhibitor 4-methylpyrazole (4-MP) or the aldehyde dehydrogenase inhibitor cyanamide prevented or augmented the ethanol-induced inhibition, respectively, in the ADH but not the FVB group. | Fomepizole | aldo-keto reductase family 1, member A1 (aldehyde reductase) | Mus musculus |
| 2 | Pretreatment with the ADH inhibitor 4-methylpyrazole (4-MP) or the aldehyde dehydrogenase inhibitor cyanamide prevented or augmented the ethanol-induced inhibition, respectively, in the ADH but not the FVB group. | Fomepizole | aldo-keto reductase family 1, member A1 (aldehyde reductase) | Mus musculus |
| 3 | Pretreatment with the ADH inhibitor 4-methylpyrazole (4-MP) or the aldehyde dehydrogenase inhibitor cyanamide prevented or augmented the ethanol-induced inhibition, respectively, in the ADH but not the FVB group. | Fomepizole | aldo-keto reductase family 1, member A1 (aldehyde reductase) | Mus musculus |
| 4 | Pretreatment with the ADH inhibitor 4-methylpyrazole (4-MP) or the aldehyde dehydrogenase inhibitor cyanamide prevented or augmented the ethanol-induced inhibition, respectively, in the ADH but not the FVB group. | Fomepizole | aldo-keto reductase family 1, member A1 (aldehyde reductase) | Mus musculus |
| 5 | The ADH transgene also substantiated the ethanol-induced inhibition of maximal velocity of shortening/relengthening and unmasked an ethanol-induced prolongation of the duration of shortening/relengthening, which was abolished by 4-MP. | Fomepizole | aldo-keto reductase family 1, member A1 (aldehyde reductase) | Mus musculus |